1. Following the 2016 Publication of MINDACT, the 2017 ASCO guidelines were updated to indicate favorable results in patients with 1-3 positive lymph nodes. MammaPrint’s 510(k) FDA clearance includes breast cancer patients with Stage 1 or Stage II disease, with tumor size ≤ 5.0 cm and lymph node negative. (Agendia is committed to delivering results in less than 10 business days, and results are provided within 6 business days for the majority of cases)
2. FDA 510(k) clearance (K201902)
3. Cardoso, F., et al. N Engl J Med 2016;375:717-29.
4. Knauer, M., et al. Breast Cancer Res Treat. 2010 Apr;120(3):655-61.